Observed Signal · Nov 2, 2026 · Market Signal · Source: GrowthCurve Capital · Impact: 2/5
TailorMed Announces Majority Investment from GrowthCurve Capital to Support Continued Growth
GrowthCurve Capital announces a majority investment in TailorMed, a healthcare financial technology company, to support its continued growth.
Track GrowthCurve Capital Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your Polaris7 workspace to monitor these entities.
Connected Companies & Entities
1 Entity mappedRelated Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Tandem Health Raises $100M Series B Led by EU Fund
Stockholm-based Tandem Health, a HealthTech startup developing an AI-native operating system for European clinics, has raised $100 million (€86.49 million) in Series B funding. The round was led by EQT's Scaleup Europe Fund, marking its first healthcare investment, with participation from existing investors Kinnevik, Northzone, Amino Collective, and Visionaries. Tandem's AI co-pilot assists clinicians by generating medical notes, preparing patient summaries, aiding clinical decisions, and automating documentation; it is certified as a Class IIa medical device under EU regulations. Used by over 10,000 care organizations across 14 European markets, including the NHS, Ramsay Santé, and Humanitas, the company has now raised a total of $160 million following a $50 million Series A last year. The funding will support European expansion, growth of its clinician-led team, and the evolution into a comprehensive AI-native clinic operating system.
a16z Leads $120M Series B in General Medicine
Andreessen Horowitz (a16z) announced it is leading a $120 million Series B funding round for General Medicine, a healthcare technology company founded by the PillPack team. General Medicine aims to create a comprehensive healthcare shopping experience by combining patient history, clinical guidance, transparent pricing, and access to care into a single platform. The company operates its own medical group alongside a marketplace of external clinicians, offering a catalog of over 2,900 health products and services. The funding will support building out the consumer offering and enterprise partnerships with health systems, payors, and pharmacies. This marks a significant investment in transforming the healthcare experience using technology.
London's Emerald secures €1.66M for preventive healthcare platform
London-based preventive healthcare platform Emerald has raised an additional €1.66 million (£1.4 million/$1.85 million) in funding, bringing its total to €3.44 million. The round includes an €832.2k grant from Innovate UK and €832.2k in venture capital from new and existing investors, including Sequel and Highgoal. The company plans to use the funds for commercial expansion, product development, and AI enhancements. Since early 2026, Emerald has grown its member base tenfold and processed over 100,000 lab tests, reporting improved health outcomes among users. The startup aims to reach one million members within three years, leveraging partnerships across employee benefits, FinTech, and fitness sectors.
Receive all future signals for GrowthCurve Capital & competitors in your briefing
Never miss material M&A deals, leadership changes, account wins, or product rollouts. Polaris7 monitors 20,000+ primary sources 24/7, delivering verified telemetry directly into your executive briefing.